Kymera Therapeutics, Inc.
KYMRNASDAQHealthcare● Active
$75.03
+$0.90(+1.21%)
Market Cap$6.2B
P/E Ratio—
52W High$103
52W Low$36.65
Kymera Therapeutics, Inc.（KYMR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KYMR · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $39.20M | $47.07M | $78.59M | $46.83M | $72.83M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $39.20M | $47.07M | $78.59M | $46.83M | $72.83M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $316.60M | $240.25M | $189.08M | $164.25M | $137.02M |
| G&A Expenses | $68.20M | $63.53M | $55.04M | $43.83M | $36.34M |
| Total Operating Expenses | $388.60M | $308.71M | $244.12M | $208.08M | $173.36M |
| Operating Income | ($349.40M) | ($261.63M) | ($165.53M) | ($161.26M) | ($100.53M) |
| Operating Margin %(computed) | -891.33% | -555.82% | -210.62% | -344.37% | -138.03% |
| Interest Income | $38.03M | $38.03M | $18.76M | $6.62M | $0.49M |
| Interest Expense | $0.25M | $0.25M | $0.20M | $0.18M | $0.17M |
| Income Before Tax | ($311.62M) | ($223.86M) | ($146.96M) | ($154.81M) | ($100.22M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($311.40M) | ($223.86M) | ($146.96M) | ($154.81M) | ($100.22M) |
| Net Margin %(computed) | -794.39% | -475.57% | -186.99% | -330.60% | -137.60% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
| Wtd Avg Shares | 84.39M | 75.04M | 58.37M | 53.93M | 47.99M |
| EBITDA | ($303.06M) | ($216.24M) | ($143.20M) | ($151.66M) | ($97.64M) |
| EBITDA Margin %(computed) | -773.11% | -459.37% | -182.21% | -323.87% | -134.07% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Kymera Therapeutics, Inc.
关于Kymera Therapeutics, Inc.（KYMR）损益表
Kymera Therapeutics, Inc.（KYMR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，KYMR实现营收$0.04B，毛利润$0.04B（毛利率100.00%），净利润($0.31B)（净利率-794.39%）。
常见问题
KYMR · 4 问Kymera Therapeutics, Inc.（KYMR）2025财年营收为$0.04B，同比down16.7%。
KYMR revenueKYMR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08